Early Access

10-KPeriod: FY2013

Elevance Health, Inc. Annual Report, Year Ended Dec 31, 2013

Filed February 20, 2014For Securities:ELV

Summary

Elevance Health, Inc. (formerly WellPoint, Inc.) reported strong revenue growth in 2013, driven primarily by its Government Business segment, largely due to the acquisition of Amerigroup. However, net income saw a slight decrease compared to the previous year, impacted by the divestiture of its 1-800 CONTACTS business, preparation costs for the Affordable Care Act (ACA), and debt extinguishment losses. The company experienced a slight decline in total medical membership, with notable decreases in Medicare and Individual segments, partially offset by growth in Medicaid. Management highlighted strategic repositioning in certain Medicare Advantage plans and continued focus on integrating acquisitions, managing healthcare costs, and enhancing digital member interactions. The company continued its capital return strategy through dividends and share repurchases.

Financial Statements
Beta
Revenue$71.02B
SG&A Expenses$9.95B
Operating Income$4.00B
Interest Expense$602.70M
Net Income$2.49B
EPS (Basic)$8.34
EPS (Diluted)$8.20
Shares Outstanding (Basic)298.50M
Shares Outstanding (Diluted)303.80M

Key Highlights

  • 1Total operating revenue increased by 16.0% to $70.2 billion in 2013, primarily driven by the acquisition of Amerigroup and growth in the Government Business segment.
  • 2Net income decreased by 6.2% to $2.5 billion in 2013, impacted by a loss on the sale of the 1-800 CONTACTS business and costs associated with the upcoming implementation of the Affordable Care Act (ACA).
  • 3Total medical membership slightly decreased by 1.3% to 35.7 million members, with declines in Medicare and Individual segments offset by growth in Medicaid.
  • 4The company repurchased $1.6 billion of its common stock in 2013 and increased its quarterly dividend by 16.7% for 2014, indicating a commitment to returning capital to shareholders.
  • 5The company is actively managing healthcare costs through various medical management programs and value-based payment initiatives.
  • 6Elevance Health's financial position remained strong, with consolidated cash, cash equivalents, and investments totaling $22.4 billion at year-end 2013.
  • 7The company is navigating the significant changes brought about by the Affordable Care Act, which is expected to present both opportunities and challenges for its business.

Frequently Asked Questions